BACKGROUND
Hidradenitis suppurativa (HS) is a chronic dermatologic condition that often necessitates surgical treatment. Surgical approaches vary substantially with little data on efficacy and safety.
OBJECTIVE
Summarize the literature on HS surgery with regards to patient characteristics, surgical approaches, and study quality. Compare postsurgical recurrence rates with a meta-analysis.
Methods
PubMed, Embase, and Scopus were searched for studies on surgical HS management published after 2004. A random effects meta-analysis of recurrence rates was performed on eligible studies.
Results
Of 715 identified studies, 59 were included in the review and 33 in the meta-analysis. Twenty-two studies of wide excision had the lowest pooled recurrence rate at 8% (95% confidence interval [CI] 2%–16%); local excision had the highest at 34% (95% CI 24%–44%). For studies of wide/radical excision, flap repair had the lowest pooled recurrence rate at 0% (95% CI 0%–4%); delayed primary closure had the highest at 38% (95% CI 20%–59%).
Conclusions
Wide excision and flap-based reconstruction are associated with a lower postsurgical HS recurrence, although this must be balanced against potentially higher morbidity of extensive procedures. Heterogeneity and methodological limitations of the evidence limit the ability to make a strong conclusion about the relative recurrence rates associated with surgical techniques.
Registration
PROSPERO ID: CRD42020159948.
AbobotulinumtoxinA is a botulinum neurotoxin type A that blocks the release of acetylcholine from peripheral cholinergic nerve terminals and thereby induces flaccid paralysis. It is the second produced botulinum neurotoxin type A of its class and is currently approved for the use in spasticity, dystonia in adults, and correction of glabellar wrinkle lines in adults up to 65 years of age. Though these are the only US Food and Drug Administration (FDA) indications for its use, there are many off-label uses for abobotulinumtoxinA such as various facial lines, hyperhidrosis, temporomandibular disease, and other neuromuscular conditions. This summary article reviews the history, development, unique properties, clinical indications, and safety profile of abobotulinumtoxinA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.